Capnocytophaga canimorsus Capsular Serovar and Disease Severity, Helsinki Hospital District, Finland, 2000-2017

Show full item record



Permalink

http://hdl.handle.net/10138/275491

Citation

Hess , E , Renzi , F , Karhunen , P , Dol , M , Lefevre , A , Antikainen , J , Carlier , E , Hästbacka , J & Cornelis , G R 2018 , ' Capnocytophaga canimorsus Capsular Serovar and Disease Severity, Helsinki Hospital District, Finland, 2000-2017 ' , Emerging Infectious Diseases , vol. 24 , no. 12 , pp. 2195-2201 . https://doi.org/10.3201/eid2412.172060

Title: Capnocytophaga canimorsus Capsular Serovar and Disease Severity, Helsinki Hospital District, Finland, 2000-2017
Author: Hess, Estelle; Renzi, Francesco; Karhunen, Panu; Dol, Melanie; Lefevre, Adrien; Antikainen, Jenni; Carlier, Elodie; Hästbacka, Johanna; Cornelis, Guy R.
Contributor organization: University of Helsinki
Clinicum
HUS Perioperative, Intensive Care and Pain Medicine
Date: 2018-12
Language: eng
Number of pages: 7
Belongs to series: Emerging Infectious Diseases
ISSN: 1080-6040
DOI: https://doi.org/10.3201/eid2412.172060
URI: http://hdl.handle.net/10138/275491
Abstract: We assembled a collection of 73 Capnocytophaga canimorsus isolates obtained from blood cultures taken from patients treated at Helsinki University Hospital (Helsinki, Finland) during 2000-2017. We serotyped these isolates by PCR and Western blot and attempted to correlate pathogen serovar with patient characteristics. Our analyses showed, in agreement with previous research, that 3 C. canimorsus serovars (A-C) caused most (91.8%) human infections, despite constituting only 7.6% of isolates found in dogs. The 3 fatalities that occurred in our cohort were equally represented by these serovars. We found 2 untypeable isolates, which we designated serovars J and K. We did not detect an association between serovar and disease severity, immune status, alcohol abuse, or smoking status, but dog bites occurred more frequently among patients infected with non-A-C serovars. Future research is needed to confirm serovar virulence and develop strategies to reduce risk for these infections in humans.
Subject: INFECTION
3121 General medicine, internal medicine and other clinical medicine
Peer reviewed: Yes
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
17_2060.pdf 1.859Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record